| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/26/2005 | EP1588166A2 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 10/26/2005 | EP1588139A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| 10/26/2005 | EP1587958A1 Method for the identification and isolation of strong bacterial promoters |
| 10/26/2005 | EP1587947A2 Production of 5'-ribonucleotides |
| 10/26/2005 | EP1587941A1 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 10/26/2005 | EP1587934A2 Improved genetic elements providing high levels of expression |
| 10/26/2005 | EP1587933A1 Novel melon plants |
| 10/26/2005 | EP1587932A1 Plant transformation with in vivo assembly of a trait |
| 10/26/2005 | EP1587931A2 Glyphosate tolerant alfalfa events and methods for detection thereof |
| 10/26/2005 | EP1587930A2 Methods and compositions for producing male sterile plants |
| 10/26/2005 | EP1587929A2 Protein purification means |
| 10/26/2005 | EP1587927A2 Regulator/promoter for tunable gene expression and metabolite sensing |
| 10/26/2005 | EP1587926A2 Lipophilic derivatives of double-stranded ribonucleic acid |
| 10/26/2005 | EP1587924A2 Methods for site-directed mutagenesis and targeted randomization |
| 10/26/2005 | EP1587922A2 Method for cloning and expression of bsrgi restriction endonuclease and bsrgi methyltransferase in e . coli |
| 10/26/2005 | EP1587921A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 10/26/2005 | EP1587920A1 Malate dehydrogenase as a target for herbicides |
| 10/26/2005 | EP1587914A2 Method for comprehensive identification of cell lineage specific genes |
| 10/26/2005 | EP1587912A2 Methods of identifying and designing cell surface receptor inhibitors |
| 10/26/2005 | EP1587908A2 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 10/26/2005 | EP1587907A2 Kunitz domain library |
| 10/26/2005 | EP1587904A2 Glycosylation modified il-20 |
| 10/26/2005 | EP1587869A2 Membrane active polymers |
| 10/26/2005 | EP1587838A2 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 10/26/2005 | EP1587834A2 Uses of mammalian cytokine; related reagents |
| 10/26/2005 | EP1587831A2 Spliced variants of lgr6 |
| 10/26/2005 | EP1587830A1 Peptide inhibitors of toxins derived from ll-37 |
| 10/26/2005 | EP1587828A1 Defensin protins |
| 10/26/2005 | EP1587825A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 10/26/2005 | EP1587819A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 10/26/2005 | EP1587574A2 SELECTIVE 11b-HSD INHIBITORS AND METHODS FOR USE THEREOF |
| 10/26/2005 | EP1587545A2 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 10/26/2005 | EP1587544A1 p53 TREATMENT OF PAPILLOMARIVUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS |
| 10/26/2005 | EP1587543A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection |
| 10/26/2005 | EP1587541A2 Compositions and methods of tolerizing a primate to an antigen |
| 10/26/2005 | EP1587533A1 A hybrid vector system for use as a vaccine |
| 10/26/2005 | EP1587524A2 Compositions and methods for targeted biological delivery of molecular carriers |
| 10/26/2005 | EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use |
| 10/26/2005 | EP1587476A2 Novel compositions and methods in cancer |
| 10/26/2005 | EP1587405A2 Novel compositions and methods for cancer |
| 10/26/2005 | EP1587364A2 Method for identifying novel treatments of inflammatory disease in the gut |
| 10/26/2005 | EP1587363A2 Protein production in transgenic avians using lentiviral system |
| 10/26/2005 | EP1587359A2 Seed-oil suppression to enhance yield of commercially important macromolecules |
| 10/26/2005 | EP1509540A4 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 10/26/2005 | EP1467815B1 Reaction vessel for carrying out array processes |
| 10/26/2005 | EP1463744A4 Devices and methods for isolating and detecting specific substances in complex matrices |
| 10/26/2005 | EP1410019B1 Cardiovascular safety assay |
| 10/26/2005 | EP1390541B1 Method for detecting gram-positive bacteria |
| 10/26/2005 | EP1366195B1 Method for the detection of nucleic acid molecules |
| 10/26/2005 | EP1365025B1 Agarase and gene thereof |
| 10/26/2005 | EP1354058B1 Isolation and characterisation of an anther-specific promoter (cofs) in cotton |
| 10/26/2005 | EP1307547B1 Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 10/26/2005 | EP1242629B1 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 10/26/2005 | EP1230396B1 Immunological detection of rna:dna hybrids on microarrays |
| 10/26/2005 | EP1194526B1 One-step allelic exchange in mycobacteria with conditional transducing phage |
| 10/26/2005 | EP1171634B1 Amplification and sequencing primer pairs and use thereof |
| 10/26/2005 | EP1161527B1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 10/26/2005 | EP1159455B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 10/26/2005 | EP1151010B1 Human polyclonal antibodies from transgenic nonhuman animals |
| 10/26/2005 | EP0988370B1 Electrospraying apparatus and method for introducing material into cells |
| 10/26/2005 | EP0977495B1 Composition comprising pectin methyl esterase and two substrates |
| 10/26/2005 | EP0973889B1 HUMAN CALCIUM CHANNELS ALFA1i SUBUNITS AND RELATED PROBES, CELL LINES AND METHODS |
| 10/26/2005 | EP0963437B1 The process for the expression and production of the recombinant human beta-cis interferon |
| 10/26/2005 | EP0938381A4 Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation |
| 10/26/2005 | EP0909273B1 Alpha-amylase transcription factor |
| 10/26/2005 | EP0876150B1 Non-toxic mutants of pathogenic gram-negative bacteria |
| 10/26/2005 | EP0711303B1 Biotinylation of proteins |
| 10/26/2005 | EP0687301B1 Prohormone convertase transformed cells and polypeptide synthesis |
| 10/26/2005 | EP0654075B1 New bacillus thuringiensis strains and their insecticidal proteins |
| 10/26/2005 | EP0625048B2 Synthesis of human procollagens and collagens in recombinant dna systems |
| 10/26/2005 | EP0506757B2 A recombinant human factor viii derivative |
| 10/26/2005 | CN1689027A Prediction by collective likelihood from emerging patterns |
| 10/26/2005 | CN1688884A Interaction detecting method and bioassay device, and bioassay-use substrate |
| 10/26/2005 | CN1688719A Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 10/26/2005 | CN1688716A Methods to assess quality of microarrays |
| 10/26/2005 | CN1688715A Marker genes for determining renal toxicity |
| 10/26/2005 | CN1688713A Method for producing ketocarotinoids in plant fruit |
| 10/26/2005 | CN1688712A Method for the production of ketocarotinoids in flower petals on plants |
| 10/26/2005 | CN1688711A Method for producing ketocarotinoids in genetically modified organisms |
| 10/26/2005 | CN1688706A Method for the production by fermentation of sulphur-containing fine chemicals (metF) |
| 10/26/2005 | CN1688703A Methods and materials for the production of L-lactic acid in yeast |
| 10/26/2005 | CN1688702A Use of recombinant measles viruses expressing epitopes of antigens of RNA viruses in the preparation of vaccine compositions |
| 10/26/2005 | CN1688701A Mechanisms of myoblast transfer in treating heart failure |
| 10/26/2005 | CN1688700A Transformed plants with enhanced prenylquinone biosynthesis |
| 10/26/2005 | CN1688699A Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 10/26/2005 | CN1688698A Novel peptide synthase gene |
| 10/26/2005 | CN1688697A Homogentisate prenyl transferase ('HPT') nucleic acids and polypeptides, and uses thereof |
| 10/26/2005 | CN1688696A GHRH analogues |
| 10/26/2005 | CN1688695A New dendritic cell co stimulatory molecules |
| 10/26/2005 | CN1688694A Cloning and characterization of the broad-spectrum resistance gene Pi2 |
| 10/26/2005 | CN1688693A Selection and isolation of living cells using mRNA-binding probes |
| 10/26/2005 | CN1688692A Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 10/26/2005 | CN1688691A Antibody variants with faster antigen association rates |
| 10/26/2005 | CN1688690A Mutant E. coli APPA phytase enzymes |
| 10/26/2005 | CN1688689A Aldehyde dehydrogenase gene |
| 10/26/2005 | CN1688687A Novel microorganism and method of treating organic solid matters with the use of the microorganism |
| 10/26/2005 | CN1688607A Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 10/26/2005 | CN1688604A Recombinant anti-osteopontin antibody and use thereof |
| 10/26/2005 | CN1688602A Novel MHC II associated peptides |
| 10/26/2005 | CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |